The remaining 14 cases (9.8%) with normal PAH genotypes lacked the recommended former dihydropteridine reductase (DHPR) and pterin evaluations [2] to discard a defect in the metabolism of BH4. Here, QDPR is linked to pulmonary arterial hypertension.